Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders: review

Pharmacol Rep. 2023 Dec;75(6):1410-1444. doi: 10.1007/s43440-023-00544-7. Epub 2023 Oct 31.

Abstract

Cannabinoid receptors, endogenous cannabinoids (endocannabinoids), and the enzymes involved in the biosynthesis and degradation of the endocannabinoids make up the endocannabinoid system (ECS). The components of the ECS are proven to modulate a vast bulk of various physiological and pathological processes due to their abundance throughout the human body. Such discoveries have attracted the researchers' attention and emerged as a potential therapeutical target for the treatment of various diseases. In the present article, we reviewed the discoveries of natural compounds, herbs, herbs formula, and their therapeutic properties in various diseases and disorders by modulating the ECS. We also summarize the molecular mechanisms through which these compounds elicit their properties by interacting with the ECS based on the existing findings. Our study provides the insight into the use of natural compounds that modulate ECS in various diseases and disorders, which in turn may facilitate future studies exploiting natural lead compounds as novel frameworks for designing more effective and safer therapeutics.

Keywords: Cannabinoid receptors; Endocannabinoid system (ECS); Herbal formulas; Herbs; Natural compounds.

Publication types

  • Review

MeSH terms

  • Endocannabinoids* / metabolism
  • Humans
  • Receptors, Cannabinoid / metabolism

Substances

  • Endocannabinoids
  • Receptors, Cannabinoid